4.8 Article Retracted Publication

被撤回的出版物: A glycolytic mechanism regulating an angiogenic switch in prostate cancer (Retracted article. See vol. 81, pg. 1623, 2021)

期刊

CANCER RESEARCH
卷 67, 期 1, 页码 149-159

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-06-2971

关键词

-

类别

资金

  1. NATIONAL CANCER INSTITUTE [P01CA093900] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013701] Funding Source: NIH RePORTER
  3. NCI NIH HHS [CA 93900] Funding Source: Medline
  4. NIDCR NIH HHS [DE 13701] Funding Source: Medline

向作者/读者索取更多资源

The generation of an 'angiogenic switch' is essential for tumor growth, yet its regulation is poorly understood. In this investigation, we explored the linkage between metastasis and angiogenesis through CXCL12/CXCR4 signaling. We found that CXCR4 regulates the expression and secretion of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1). Overexpression of PGK1 reduced the secretion of vascular endothelial growth factor and interleukin-8 and increased the generation of angiostatin. At metastatic sites, however, high levels of CXCL12 signaling through CXCR4 reduced PGK1 expression, releasing the angiogenic response for metastastic growth. These data suggest that PGK1 is a critical downstream target of the chemokine axis and an important regulator of an 'angiogenic switch' that is essential for tumor and metastatic growth.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据